In collaboration with our colleagues working in the antiviral, antibacterial, aging, neuroscience, and cardiovascular areas, my laboratory have studied mechanisms and have developed a number of potent inhibitors as potential therapeutics for HBV, HCV, sarcoidosis, migraine, Alzheimer’s, tuberculosis, and cardiovascular diseases.